Elevance Health beats top-line and bottom-line estimates; raises FY26 outlook

Goldman Sachs (GS): Buy, Sell, or Hold Post Q2 Earnings?

2026/08/04

3 Big Reasons to Love Netflix (NFLX)

2026/08/04

2 Reasons to Avoid CNS and 1 Stock to Buy Instead

2026/08/04

Palantir outlines 2026 revenue of $8.15B-$8.158B as U.S. commercial guidance rises above $3.424B

2026/08/04